Prostate cancer between prognosis and adequate/proper therapy - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/28255369/

Knowing the indolent, non-invasive nature of most types of prostate cancer, as well as the simple fact that the disease seems more likely to be associated with age rather than...

Adding short-term androgen deprivation therapy to RT in men with localized prostate cancer: long-term update of the NRG/RTOG 9408 randomized clinical trial - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34481017/

1 Sutter Medical Center Sacramento, 2 Medical Plaza Drive, Roseville, CA 95661. Electronic address: [email protected]. 2 NRG Oncology Statistics and Data Management Center, 50 South 16th Street, Suite 2800 |...

Radiation therapy with curative intention in men with de novo metastatic prostate carcinoma: shoot'em all! - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34434577/

Background: About 5% of prostate cancer cases are metastatic at diagnoses. Radiotherapy of both primary tumor and secondary lesions can be, in addition to systemic treatments, a radical alternative for...

Pathological stage, surgical margin and lymphovascular invasion as prognostic factors after salvage radiotherapy for post-prostatectomy relapsed prostate cancer - outcomes and optimization strategies - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34434569/

1 External Radiotherapy Department, Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E., Portugal. 2 Urology Clinic, Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E, Portugal. Free PMC article...

Immunotherapy in treatment of metastatic prostate cancer: An approach to circumvent immunosuppressive tumor microenvironment - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34435699/

Prostate cancer is the second most common cause of cancer-related death in men in the United States and the fifth worldwide. Most prostate cancer arises as an androgen-dependent tumor but...